{"name":"Flurazepam","slug":"flurazepam","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Insumin","Flurazepamum","Dalmane-R","Felison","Ro-5-6901/3","Dormodor","Apo Flurazepam","Flurazepam Mono Perchlorate","Mono-Perchlorate, Flurazepam","N05cd01"],"brands":[],"scraped":true,"has_structure":true,"cid":3393,"classes":[],"families":[{"name":"aniline","href":"/substituted/aniline"},{"name":"benzodiazepine","href":"/substituted/benzodiazepine"}],"physical":[{"label":"Molecular mass","value":"387.90 g/mol","copyable":false},{"label":"Appearance","value":"White rods from ether-petroleum ether","copyable":false},{"label":"Melting point","value":"190-220","copyable":false},{"label":"Solubility","value":"500 mg/mL (HCl salt)","copyable":false},{"label":"Predicted LogP","value":"3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>21</sub>H<sub>23</sub>ClFN<sub>3</sub>O","copyable":true},{"label":"IUPAC name","value":"7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one","copyable":true},{"label":"SMILES","value":"CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F","copyable":true},{"label":"InChI","value":"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3","copyable":true},{"label":"InChIKey","value":"SAADBVWGJQAEFS-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"17617-23-1","copyable":true},{"label":"UNII","value":"IHP475989U","copyable":true},{"label":"PubChem CID","value":"3393","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"2.3 hours, N-desalkylflurazepam: 47–100 hours","copyable":false},{"label":"Metabolism","value":"Liver","copyable":false},{"label":"Excretion","value":"Kidney","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false},{"label":"Addiction liability","value":"Moderate","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"ip","dose":"290 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"oral","dose":"870 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"iv","dose":"84 mg/kg"}]]]}],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[{"reagent":"Froehde","reacts":true,"colors":["#ffffff","#fd7322"],"description":"orange"},{"reagent":"Zimmermann","reacts":true,"colors":["#ffffff","#d59aca","#50268d"],"description":"violet / purple"}],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CD","description":"Benzodiazepine derivatives"},{"code":"N05CD01","description":"Flurazepam"}],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"},{"name":"Anti-Anxiety Agents","id":"M0021771"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"GABRA1","mechanisms":["shared target"],"partners":37,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":34,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":34,"contraindicated":0}],"mechanism":"Flurazepam binds to an allosteric site on GABA-A receptors. Binding potentiates the action of GABA on GABA-A receptors by opening the chloride channel within the receptor, causing chloride influx and hyperpolarization.","side_effects":{"drug_id":3393,"drug_name":"flurazepam","url":"https://sideeffects.embl.de/drugs/3393/pt","atc_codes":["N05CD01"],"side_effects":[{"name":"Agranulocytosis","cui":"C0001824"},{"name":"Decreased appetite","cui":"C0232462"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Asthenia","cui":"C0004093"},{"name":"Ataxia","cui":"C0004134"},{"name":"Chest pain","cui":"C0008031"},{"name":"Coma","cui":"C0009421"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Lightheadedness","cui":"C0220870"},{"name":"Somnolence","cui":"C2830004"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Flushing","cui":"C0016382"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Hypotension","cui":"C0020649"},{"name":"Irritability","cui":"C0022107"},{"name":"Lethargy","cui":"C0023380"},{"name":"Leukopenia","cui":"C0023530"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Palpitations","cui":"C0030252"},{"name":"Pruritus","cui":"C0033774"},{"name":"Salivary hypersecretion","cui":"C0037036"},{"name":"Withdrawal syndrome","cui":"C0038587"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Vomiting","cui":"C0042963"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Agitation","cui":"C0085631"},{"name":"Excitement","cui":"C0233571"},{"name":"Hyperkinesia","cui":"C0424295"},{"name":"Blood alkaline phosphatase increased","cui":"C0852911"},{"name":"Aspartate aminotransferase increased","cui":"C0151904"},{"name":"Disorientation","cui":"C0233407"},{"name":"Anxiety","cui":"C0003467"},{"name":"Thinking abnormal","cui":"C0233632"},{"name":"Mental disability","cui":"C1306341"},{"name":"Dysarthria","cui":"C0013362"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Dysgeusia","cui":"C0013378"},{"name":"Abdominal discomfort","cui":"C0232487"},{"name":"Drug intolerance","cui":"C0277585"},{"name":"Anaphylactic shock","cui":"C0002792"},{"name":"Anaphylactoid reaction","cui":"C0340865"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Gait disturbance","cui":"C0575081"},{"name":"Logorrhoea","cui":"C3248383"}],"indications":[{"name":"Insomnia","cui":"C0917801"},{"name":"Terminal insomnia","cui":"C0541798"}]},"effects":null,"usernotes":[{"user":"nervewing","user_slug":"nervewing","external":false,"note":{"substance":"Flurazepam","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning IV, In general: ℞ (Prescription only)","act":null,"refs":[4]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Flurazepam"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/3393"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q418998"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00690"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL968"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A5128"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=17617-23-1"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014828"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D00329"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID1023071"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Flurazepam"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/IHP475989U"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/3393/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 3393, Flurazepam. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/3393>https://pubchem.ncbi.nlm.nih.gov/compound/3393</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Flurazepam. UNII: IHP475989U. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/IHP475989U>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/IHP475989U</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika. Läkemedelsverket. <a href='https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf'>https://www.lakemedelsverket.se/globalassets/dokument/lagar-och-regler/lvfs/lvfs-2011-10-konsoliderad.pdf</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:00:26","note":"no dosing statistics"},{"source":"drugspro","status":"ok","fetched_at":"2026-11-20 18:00:22","note":null},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:00:22","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:00:22","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:00:22","note":"hmdb.ca refused automated access to HMDB0014828"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:00:24","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:00:21","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:00:22","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:00:22","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:00:22","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:00:22","note":null}],"description":"Flurazepam is a  substance."}